Sage Group News

Sage Group Advises APR on InLicensing and Acquisition of Novel Pharma Products

ABOUT APR Applied Pharma Research s.a. (; “APR” or the “Company”) is a profitable, well-financed, privately held, Swiss developer of specialty healthcare products, with over 20 years of experience. APR has a proven track record in successfully developing and marketing novel products in various therapeutic areas on a global basis. APR identifies, in-licenses, develops (using 'state-of-the-art' technology, innovative formulations, dosage forms and delivery systems) and then commercializes through partners, science driven, branded products with unique selling points designed to address patient needs in niche or rare therapy areas. APR’s business strategy starts from an understanding o